Category
An FDA Warning Letter is a significant regulatory escalation that demands immediate attention. This comprehensive 2026 guide explains what these letters mean for your business, the common triggers for issuance,…
Failing an FDA inspection can lead to Warning Letters and costly shutdowns. This comprehensive 2500-word guide explores the top 20 reasons for inspection failure, ranging from poor data integrity to…
The period following an investigator's visit is critical for regulatory survival. This guide explains what happens after an FDA inspection, detailing the high-stakes transition from receiving a Form 483 to…
The Modernization of Cosmetics Regulation Act (MoCRA) has transformed how the FDA monitors the beauty industry. This comprehensive guide analyzes recent cosmetic labeling violations found in 2025-2026 warning letters. Learn…
Handling FDA 483 observations on sterility and potency requires a precise technical response. This guide explores how Pharmaceutical QA teams can address regulatory findings, implement robust CAPA systems, and ensure…
Stay ahead of regulatory shifts with our deep dive into FDA pharmaceutical CGMP inspection trends from 2025-2026. This comprehensive guide analyzes recent warning letters to reveal common pitfalls in data…
Receiving an FDA warning letter is a critical event for any regulated company. It signals significant regulatory violations that require immediate and thorough attention. A poorly crafted response can escalate…
Receiving an FDA warning letter can severely impact a medical device company's operations, reputation, and financial stability. These letters signify serious regulatory violations that were not adequately addressed after an…
Receiving an FDA Warning Letter is one of the most serious regulatory events that can occur for any manufacturer in the United States. It is not merely a slap on…
On March 2, 2017, a US Food and Drug Administration (USFDA) Warning Letter was issued to seafood importers, Lucky Pacific Corp and Kamli International Co. Ltd. This Warning Letter was…
Sign in to access member resources, inspection tools and training.
New here? Create an account
